<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04583683</url>
  </required_header>
  <id_info>
    <org_study_id>20203009</org_study_id>
    <nct_id>NCT04583683</nct_id>
  </id_info>
  <brief_title>Effects of Very Low Calorie Diet vs Metabolic Surgery on Weight Loss and Obesity Comorbidities</brief_title>
  <acronym>ARGOS</acronym>
  <official_title>Effects of Very Low Calorie Diet vs Metabolic Surgery on Weight Loss and Obesity Comorbidities: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is a prospective randomized trial on 218 subjects, 109 for each arms. The purpose of this&#xD;
      trial is to compare very low calorie diet and metabolic surgery induced weight loss and its&#xD;
      maintenance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity is a leading public health issued associated with poor quality of life, morbidity and&#xD;
      an increased mortality rate. Although metabolic surgery results in a greater weight loss when&#xD;
      compared to non-surgical approaches, a low calorie diet associated with intensive maintenance&#xD;
      session may be a valid alternative for weight loss. Since lifestyle interventions are safer&#xD;
      and potentially more cost effective than metabolic surgery, this trial will test whether an&#xD;
      intensive lifestyle intervention is as effective as metabolic surgery to induce weight loss&#xD;
      and its maintenance.&#xD;
&#xD;
      A total of 218 participants will be randomly assigned to metabolic surgery (109) or intensive&#xD;
      lifestyle intervention (109).&#xD;
&#xD;
      Clinical outcomes will be assessed at 25% reduction in Body Mass Index (BMI), at 12 months&#xD;
      and 24 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 30, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Actual">December 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to achieve a 25% reduction in Body Mass Index</measure>
    <time_frame>1-12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants who achieve 25% reduction in Body Mass Index</measure>
    <time_frame>1-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to achieve 25% reduction in Body Mass Index</measure>
    <time_frame>1-24months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in body composition (lean mass-all tissues in the body except bone and fat-fat mass, bone density and visceral fat) using dual energy X-ray absorptiometry (DXA), from baseline, at 25% weight loss, at 12 months follow up and at 24 months follow up</measure>
    <time_frame>1-24months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in glycated hemoglobin (HbA1c), from baseline, at 12 and 24 months follow up (patients with diabetes)</measure>
    <time_frame>1-24months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fasting glucose and fasting insulin, from baseline, at 12 and 24 months follow up</measure>
    <time_frame>1-24months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in insulin resistance (assessed by HOMA-IR), from baseline, at 12 and 24 months follow up</measure>
    <time_frame>1-24months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure, from baseline, at 12 and 24 months follow up</measure>
    <time_frame>1-24months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total, HDL, LDL and total cholesterol from baseline, at 12 and 24 months follow up</measure>
    <time_frame>1-24months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in triglycerides from baseline, at 12 and 24 months follow up</measure>
    <time_frame>1-24months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants who maintain weight loss at 24 months follow up</measure>
    <time_frame>1-24months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">218</enrollment>
  <condition>Obesity, Morbid</condition>
  <condition>Obesity</condition>
  <condition>Diet, Healthy</condition>
  <condition>Bariatric Surgery Candidate</condition>
  <arm_group>
    <arm_group_label>Intensive lifestyle modification: Very low calorie diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo a very low calorie diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metabolic Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo metabolic surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Very low calorie diet with Fortimel (Nutricia) supplementation</intervention_name>
    <description>Patients will undergo a very low calorie diet</description>
    <arm_group_label>Intensive lifestyle modification: Very low calorie diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Metabolic Surgery</intervention_name>
    <description>Patients will undergo metabolic surgery</description>
    <arm_group_label>Metabolic Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged between 19 and 69 years&#xD;
&#xD;
          -  Body Mass Index ≥35 kg/m2 and at least one or more obesity-related co-morbidities such&#xD;
             as type II diabetes (T2DM), hypertension, sleep apnea and other respiratory disorders,&#xD;
             non-alcoholic fatty liver disease, osteoarthritis, lipid abnormalities,&#xD;
             gastrointestinal disorders, or heart disease&#xD;
&#xD;
          -  Body Mass Index ≥40 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Active cancer&#xD;
&#xD;
          -  End stage renal failure&#xD;
&#xD;
          -  End stage liver failure&#xD;
&#xD;
          -  Being unable to understand and sign informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Catholic University School of Medicine</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>September 30, 2020</study_first_submitted>
  <study_first_submitted_qc>October 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2020</study_first_posted>
  <last_update_submitted>May 23, 2021</last_update_submitted>
  <last_update_submitted_qc>May 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Geltrude Mingrone</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

